In a retrospective study we In the diabetic group 11 patients (16-7%) were controlled by diet, 39 (59-1%) were controlled on oral hypoglycaemic agents alone, 15 (22-7%) were on insulin, and one (1-5%) required both
Diabetes mellitus is a common condition, affecting 1-2% of the population. Cataract occurs earlier in diabetics than in non-diabetics, and both cataract and retinopathy are related to the age of the patient and the duration of the diabetes. 2 In the diabetic group 11 patients (16-7%) were controlled by diet, 39 (59-1%) were controlled on oral hypoglycaemic agents alone, 15 (22-7%) were on insulin, and one (1-5%) required both (Table 3) .
In eyes with proliferative retinopathy or maculopathy it may be more useful to consider improvement in vision rather than final visual acuity. In the proliferative group six of 10 eyes showed an improvement of 32 lines Snellen acuity, and in those with maculopathy seven of 19 showed an improvement of 32 lines Snellen acuity (Fig 3) .
PROGRESSION OF RETINOPATHY
Twenty-five diabetics showed progression of retinopathy in the follow-up period. Five eyes without retinopathy preoperatively developed background retinopathy (one with maculopathy). In the background group two eyes developed a new maculopathy, four eyes showed progression of pre-existing maculopathy, and six eyes developed preproliferative or proliferative retinopathy. In these last six eyes ihe maculopathy also progressed (in four within six months ofsurgery), while the fellow eye remained stable. In the proliferative group five eyes developed further new vessels and six showed progression of their maculopathy (three within six months of surgery). Overall, nine eyes developed severe maculopathy in the early postoperative period. Seven of these had pre-existing maculopathy and five had had previous laser photocoagulation.
Seventeen eyes required laser treatment postoperatively. Three eyes had panretinal photocoagulation (PRP) only, seven eyes had focal macular treatment only, and seven eyes had combined PRP and focal macular treatment. In none of these cases did the presence of an IOL prevent adequate photocoagulation.
COMPLICATIONS
There were few operative complications. In the control group, there was one case of vitreous loss and one posterior capsule tear. There were no operative complications in the diabetic group.
Of the postoperative complications macular oedema (diabetic and cystoid), severe inflammation, rubeosis iridis, neovascular glaucoma, and vitreous haemorrhage occurred more frequently in the diabetic group (Table 4) . Four diabetics' eyes and five control eyes developed classical cystoid macular oedema postoperatively; all Severe inflammation or infection, defined as iritis persisting for more than six weeks postoperatively, endophthalmitis, or keratitis, was more common in the diabetic group (Table 4 In conclusion, we consider that diabetics should no longer be excluded from the optical advantages of an IOL and that they have satisfactory visual results from this form of aphakic correction. However, these patients should be followed up closely postoperatively and any progressive retinopathy treated promptly.
